SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : bluebird bio Inc.
BLUE 4.9700.0%Jun 2 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche6/3/2015 4:25:15 PM
   of 163
 
Bedfellows until if and when....

On a product candidate-by-product candidate basis, up through a specified period following enrollment of the first patient in an initial Phase I clinical study for such product candidate, bluebird has granted Celgene an option to obtain an exclusive worldwide license to develop and commercialize such product candidate pursuant to a written agreement, the form of which bluebird has already agreed upon, provided that, if Celgene does not exercise its option with respect to the first product candidate under the amended collaboration then it will not be permitted to exercise its option with respect to any future product candidates under the amended collaboration. In the event that Celgene exercises its option with respect to any product candidate, bluebird may elect to co-develop and co-promote the product candidate in the United States, provided that, if bluebird does not exercise its option co-develop and co-promote the first product candidate in-licensed by Celgene under the amended collaboration agreement, then bluebird will not be permitted to exercise its option to co-develop and co-promote any future product candidates under the amended collaboration agreement.

sec.gov

edit: "Pipeline Update" webcast starting NOW.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News